Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|February 12, 2013
Potential complications of transcatheter aortic valve implantation (TAVI)-an autopsy perspectiveHeike Loeser, Maike Wittersheim, Katharina Puetz, et al.
American Journal of Nephrology|April 15, 2015
ET-1 Induced Downregulation of MRP2 via miRNA 133a - A Marker for Tubular Nephrotoxicity?Heike Loeser, Melanie von Brandenstein, Angela Herschung, et al.
Diagnostic Pathology|March 28, 2024
Concurrent KRAS p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer: a case reportTillmann Bedau, Carina Heydt, Udo Siebolts, et al.
Molecular and Clinical Oncology|May 23, 2017
Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug targetHeike Loeser, Dirk Waldschmidt, Fabian Kuetting, et al.
Therapeutic Advances in Medical Oncology|June 18, 2020
Mesothelin expression in esophageal adenocarcinoma and squamous cell carcinoma and its possible impact on future treatment strategiesValeska Moentenich, Erdem Comut, Florian Gebauer, et al.
Journal of Immunology Research|October 8, 2020
Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal AdenocarcinomaHeike Loeser, Max Kraemer, Florian Gebauer, et al.
Oncology Letters|May 12, 2020
Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategiesValeska Moentenich, Florian Gebauer, Erdem Comut, et al.
Annals of Surgical Oncology|April 11, 2022
Long-Term Outcome After Histopathological Complete Response with and Without Nodal Metastases Following Multimodal Treatment of Esophageal CancerWolfgang Schroeder, Markus P H Ghadimi, Hans Schloesser, et al.
Scientific Reports|October 28, 2020
Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survivalHeike Loeser, Matthias Scholz, Hans Fuchs, et al.
Pageof 3